You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 2, 2025

Details for Patent: 11,571,518


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,571,518 protect, and when does it expire?

Patent 11,571,518 protects ZIMHI and is included in one NDA.

This patent has ten patent family members in nine countries.

Summary for Patent: 11,571,518
Title:Emergency devices
Abstract:Described herein are syringe devices comprising a syringe including a therapeutic dose of at least one drug to be used in a drug or substance overdose.
Inventor(s):Mark J. Flather, Karen K. Daniels, Thomas Moll
Assignee:Zmi Pharma Inc
Application Number:US16/422,639
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a U.S. Patent: A Detailed Analysis of United States Patent 11,571,518

Introduction

Patents are a cornerstone of innovation, providing inventors with exclusive rights to their creations in exchange for public disclosure. To delve into the specifics of a patent, it is crucial to understand the scope and claims of the patent, as well as the broader patent landscape. This article will provide a detailed analysis using the example of United States Patent 11,571,518, although the specific details of this patent are not provided here, we will use general principles to guide the analysis.

The U.S. Patent System Overview

The U.S. patent system, established in 1790, is governed by the U.S. Constitution and subsequent laws enacted by Congress. The U.S. Patent and Trademark Office (USPTO) is responsible for granting patents and registering trademarks[2].

Patentability Requirements

For an invention to be patentable, it must meet several criteria:

  • Usefulness: The invention must be operable and provide some tangible benefit.
  • Novelty: The invention must not be fully anticipated by prior patents, publications, or other state of the art knowledge.
  • Nonobviousness: The invention must not have been readily within the ordinary skills of a competent artisan at the time it was made[1].

Patent Scope and Claims

What are Patent Claims?

Patent claims define the scope of the invention and are crucial in determining what is protected by the patent. Claims are typically divided into independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[3].

Metrics for Measuring Patent Scope

Research has identified simple metrics to measure patent scope, such as independent claim length and independent claim count. These metrics can indicate the breadth and clarity of the patent claims. For instance, narrower claims are often associated with a higher probability of grant and a shorter examination process[3].

Analyzing the Claims of a Patent

To analyze the claims of a patent like United States Patent 11,571,518, one would need to:

  • Identify Independent and Dependent Claims: Determine which claims are independent and which are dependent. Independent claims provide the broadest definition of the invention.
  • Understand Claim Language: Analyze the language used in the claims to determine the scope of protection. This includes understanding any limitations or specific embodiments described.
  • Evaluate Claim Breadth: Assess whether the claims are narrow and specific or broad and general. Broader claims may face more scrutiny during the examination process and could be more susceptible to challenges post-grant[3].

Patent Landscape and Related Patents

Global Dossier and Public Search Facilities

Tools like the Global Dossier and the USPTO Public Search Facility can help in understanding the patent landscape. The Global Dossier provides access to file histories of related applications from participating IP Offices, allowing users to see the patent family and related applications[4].

Prior Art and Patent Families

To fully understand the scope of a patent, it is essential to review prior art and the patent family. Prior art includes all existing knowledge and inventions that could affect the novelty and nonobviousness of the patent. The patent family includes all related applications filed in different jurisdictions, which can provide insights into the evolution and scope of the invention.

Challenges and Validity of Patents

Patent Quality and Validity Challenges

The quality of patents is a significant concern. Poor quality patents, which may be overly broad or unclear, can hinder innovation by increasing licensing and litigation costs. The Leahy-Smith America Invents Act introduced the Patent Trial and Appeal Board (PTAB) to challenge the validity of issued patents, which has been a subject of debate and reform proposals[1].

Litigation and Infringement

Patent infringement is a serious issue, and cases often involve complex legal battles. For example, in the case of Provisur Technologies, Inc. v. Weber, Inc., the court had to determine whether there was substantial evidence to support claims of infringement and willfulness. Such cases highlight the importance of clear and valid patent claims[5].

Equity in Innovation

Diversity and Inclusion in Patent Policy

The quality and diversity of inventive ideas are crucial for U.S. technological competitiveness. Equity-related aspects of patent policy, such as ensuring that all inventors have equal access to the patent system, are increasingly important. This includes addressing issues like patent subject matter eligibility standards and ensuring that the patent system does not disproportionately favor certain groups over others[1].

Key Takeaways

  • Patent Claims Define Scope: The claims of a patent are critical in determining what is protected.
  • Metrics for Scope: Independent claim length and count can be used to measure patent scope.
  • Patent Quality Matters: Poor quality patents can hinder innovation and increase legal costs.
  • Global Tools: Utilize tools like the Global Dossier to understand the broader patent landscape.
  • Equity in Innovation: Ensuring diversity and inclusion in the patent system is vital for technological competitiveness.

FAQs

What are the main criteria for an invention to be patentable in the U.S.?

An invention must be useful, novel, and nonobvious to be patentable in the U.S.

How do independent and dependent claims differ in a patent?

Independent claims stand alone and define the invention broadly, while dependent claims refer back to and further limit the independent claims.

What is the role of the Patent Trial and Appeal Board (PTAB)?

The PTAB is responsible for challenging the validity of issued patents, providing a mechanism to ensure that only valid patents are enforced.

How can the Global Dossier help in patent analysis?

The Global Dossier provides access to file histories of related applications from participating IP Offices, allowing users to see the patent family and related applications.

Why is patent quality important?

Poor quality patents can breed uncertainty, increase licensing and litigation costs, and make investing in innovation riskier, thereby hindering overall innovation.

Sources

  1. Congressional Research Service, "Patents and Innovation Policy," June 25, 2022.
  2. USA.gov, "U.S. Patent and Trademark Office (USPTO)."
  3. SSRN, "Patent Claims and Patent Scope," September 29, 2016.
  4. USPTO, "Search for patents."
  5. United States Court of Appeals for the Federal Circuit, "Provisur Technologies, Inc. v. Weber, Inc.," October 2, 2024.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 11,571,518

Showing 1 to 3 of 3 entries

International Family Members for US Patent 11,571,518

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 2019272966 ⤷  Try for Free
Canada 3100913 ⤷  Try for Free
China 112469458 ⤷  Try for Free
European Patent Office 3801699 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 4 of 4 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.